FUJIFILM Medical Systems U.S.A., Inc. announced it will showcase its portfolio of Synapse® Enterprise Imaging solutions at the 2021 Society for Imaging Informatics in Medicine (SIIM) Conference taking place May 24- 27.
Inspirata and Fujifilm UK Partnership Generates NHS Success with One Dorset Pathology Network Digital Pathology Engagement
May 19, 2021 04:00 ET | Source: Inspirata, Inc. Inspirata, Inc. Tampa, Florida, UNITED STATES
London, United Kingdom, May 19, 2021 (GLOBE NEWSWIRE) Cancer informatics and digital pathology provider Inspirata announced today that University Hospitals Dorset NHS Foundation Trust will commence an implementation of its Dynamyx™ digital pathology software (“Dynamyx”), as part of an agreement struck between enterprise partner, FUJIFILM UK Limited (“Fujifilm UK”) and the One Dorset Pathology network. The introduction of Dynamyx at One Dorset Pathology represents the first of several new wins for Fujifilm UK using our software, and is a direct award from the PathLAKE digital and computational pathology consortium.
Inspirata, Inc : Inspirata and Fujifilm UK Partnership Generates NHS Success with One Dorset Pathology Network Digital Pathology Engagement finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
(PRNewsfoto/Fujifilm)
LEXINGTON, Mass. and IRVINE, Calif., May 12, 2021 /PRNewswire/ FUJIFILM Medical Systems U.S.A., Inc., a leading provider of biomarkers to assess the risk for the development of hepatocellular carcinoma (HCC), and Helio Health, an AI-driven healthcare company developing early cancer detection tests, today announced their collaboration to provide a blood-based assay that can help with the earlier detection of liver cancer. Through this relationship, Helio Health’s DNA methylation and biomarker-based blood test technology, recognized as the HelioLiver Test, will leverage Fujifilm’s 510(k)-cleared µTASWako® i30 Immunological test system for liver cancer biomarkers.
Liver cancer is the fastest growing and second deadliest cancer worldwide. According to the American Cancer Society, liver cancer incidence rates have more than tripled since 1980, while the death rates have more than doubled during this time. Studies show that early detection of liver cancer i
Newport Beach, CA (PRWEB) February 16, 2021 Today, Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions, and